Quick Answer
BioRestorative Therapies, Inc. reported Net Income of -$14.24 million for fiscal year 2025.
BioRestorative Therapies, Inc. Net Income — Annual History
| Fiscal Year | Net Income | YoY Change |
|---|---|---|
| 2025 | -$14.24M | -58.6% |
| 2024 | -$8.98M | +13.8% |
| 2023 | -$10.42M | +43.7% |
| 2022 | -$18.49M | +58.3% |
| 2021 | -$44.30M | -293.0% |
| 2020 | -$11.27M | +23.0% |
| 2019 | -$14.65M | -17.0% |
| 2018 | -$12.52M | -32.5% |
| 2017 | -$9.44M | -9.4% |
| 2016 | -$8.64M | -9.0% |
| 2015 | -$7.92M | -41.8% |
| 2014 | -$5.59M | +2.8% |
| 2013 | -$5.75M | +12.0% |
| 2012 | -$6.54M | -60.5% |
| 2011 | -$4.07M | -80.0% |
| 2010 | -$2.26M | -89.1% |
| 2009 | -$1.20M | — |
| 2008 | $0.00 | — |
Quarterly Net Income
| Quarter Ending | Net Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$3.04M | -178.4% | -14.4% |
| June 30, 2025 | -$2.66M | +34.1% | +50.3% |
| March 31, 2025 | -$5.34M | -140.2% | -389.3% |
| September 30, 2024 | -$1.09M | -122.9% | +72.9% |
| June 30, 2024 | -$4.03M | +29.4% | -81.2% |
| March 31, 2024 | -$2.22M | +69.0% | -146.6% |
| September 30, 2023 | $4.77M | +202.4% | +183.5% |
| June 30, 2023 | -$5.71M | -22.1% | +20.4% |
- BioRestorative Therapies, Inc. showed a decrease of -58.6% in Net Income compared to the prior fiscal year.
- The most recent figure is from BioRestorative Therapies, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 26, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: